CVS Health marks 1 year of Arizona VA, TriWest program
CVS Health has offered an update on its joint initiative between the Phoenix Veterans Affairs Healthcare System and TriWest Healthcare Alliance as it marks the first year of the collaboration. In the past year, the company said 1,500 veterans have been treated at the 25 participating Phoenix-area MinuteClinic locations.
“We are thrilled with the success of the partnership between VA and MinuteClinic,” said RimaAnn Nelson, Phoenix VA Health Care System director. “To give the veteran the ability to seek care for minor conditions and illnesses at a MinuteClinic means increased access, not only for those going to MinuteClinic, but also for those with more serious illnesses and injuries who need a higher level of care in our Emergency Department. Feedback we have received from veterans who have taken advantage of this partnership has been extremely and consistently positive.”
Through the partnership, VAHCS nurses can connect veterans to MinuteClinic for treatment of minor illnesses or injuries, if they deem it clinically appropriate, through the Veterans Choice program. Veterans have been treated for such ailments as bronchitis, the flu and minor skin conditions, with them waiting roughly 30 minutes on average, CVS Health said.
“We are pleased to have been able to introduce Phoenix-area veterans to MinuteClinic this past year,” MinuteClinic vice president of clinical transformation and medical oversight Tobias Barker said. “At MinuteClinic, we are committed to ensuring that the veterans we serve receive high-quality and convenient health care when they need it and where they want it.”
MinuteClinic shares veterans’ visit summaries with their primary care physician in an effort to better coordinate care, CVS Health said, noting that it offers up-to-date clinical information for potential follow-up appointments. Patients are able to call the Phoenix VA Healthcare System’s Help Line to refer them to a MinuteClinic location, with the system noting that it expanded the hours of the line to offer more access for patients on evenings and weekends.
CVS Health expands West Virginia opioid disposal
CVS Health is bringing medication disposal kiosks to 19 CVS Pharmacy locations in West Virginia. The kiosks, the first in CVS Pharmacy stores, join the five that CVS Health has donated to police departments in the state, and accompany a $20,000 CVS Health Foundation grant to Westbrook Health Services in Parkersburg, W. Va., to support opioid addiction recovery.
“CVS Health is dedicated to addressing and preventing opioid abuse and misuse in the communities we serve,” CVS Health vice president of professional services Thomas Davis said. “We are expanding our safe medication disposal efforts to provide more locations where people can safely dispose of unwanted medications, getting them out of medicine cabinets where they could be abused. Our safe medication disposal initiative, and our funding for community organizations supporting addiction recovery in West Virginia, are an extension of CVS Health’s purpose of helping people on their path to better health.”
Through the more than 850 units that CVS Health has donated to police departments nationwide, it has collected more than 140 metric tons of unwanted medication, the company said.
Grant recipient Westbrook Health Services offer behavioral health services in eight West Virginia counties. CVS Health said the grant will support the organization’s Community Partner Outreach Initiative for Healthy Outcomes, through which it educates and connects people struggling with substance use disorder to community programs and services. The grant will improve training, which will benefit 3,000 patients in Westbrook’s treatment center and 5,000 local students through community outreach, CVS Health said.
“The funding Westbrook Health Services received from CVS Health allows us to provide valuable training in substance use disorder for Westbrook staff and the community at large,” Westbrook marketing coordinator Liz Ford said. “Through this support, we are better able address the opioid epidemic throughout West Virginia, which is critical to delivering a healthier community.”
Sanofi to unload European generics business
Sanofi and Advent International are negotiating the sale of Sanofi’s European generics business Zentiva to the global investment company for €1.9 billion. Advent’s fully financed offer would support Zentiva’s management team to invest in operations, production facilities and research and development capabilities, the companies said.
“Zentiva is a robust business with a highly talented workforce and we believe it has demonstrated its potential for growth,” Sanofi CEO Olivie Brandicourt said. “Following a comprehensive review of strategic options for our generic unit in Europe, we have determined that transferring this business to Advent is the best option to ensure its long-term success.”
Sanofi said that Zentiva is not part of its core business, and the sale is part of its strategy to simplify and reshape the company.
“We have long been attracted to the generics pharmaceutical sector as it enables more people to access high quality treatments by lowering their cost,” said Advent managing director and co-head of its European healthcare team Tom Allen and Advent managing director Cédric Chateau. “We believe that Zentiva is a great platform, full of talented people, who we can invest behind to build a new, independent, European generics leader.”
The companies said they expect the transaction to close by the end of 2018, pending finalization of agreements and regulatory approval.